Page 35 - 74_04

VOL. 74 (4) RESISTENCIA A INSULINA EN EL MÚSCULO...

(44) HEVENER, A. L.; HE, W.; BARAK, Y.; LE, J.; BANDYOPADHYAY, G.; OLSON, P.;
WILKES, J.; EVANS, R. M. AND OLEFSKY, J. (2003) Muscle-specific Pparg
deletion causes insulin resistance. Nat. Med. 9: 1491-7.

(45) VALVERDE, A. M.; BENITO, M. AND LORENZO, M. (2005) The brown adipose
cell: a model for understanding the molecular mechanisms of insulin
resistance. Acta Physiol. Scand. 183: 59-73.

(46) LESSARD, S. J.; CHEN, Z. P.; WATT, M. J.; HASHEM, M.; REID, J. J.; FEBBRAIO,
M. A.; KEMP, B. E. AND HAWLEY, J. A. (2006) Chronic rosiglitazone treatment
restores AMPKalpha2 activity in insulin-resistant rat skeletal muscle. Am. J.
Physiol. Endocrinol. Metab. 290: E251-7.

(47) LAFFITTE, B.A.; CHAO, L.C.; LI, J.; WALCZAK, R.; HUMMASTI, S.; JOSEPH, S. B.;
CASTRILLO, A.; WILPITZ, D.C.; MANGELSDORF, D. J.; COLLINS, J. L.; SAEZ, E.
AND TONTONOZ P. (2003) Activation of liver X receptor improves glucose
tolerance through coordinate regulation of glucose metabolism in liver and
adipose tissue. Proc. Natl. Acad. Sci. U S A. 100: 5419-24.

(48) STEFFENSEN, K. R. AND GUSTAFSSON, J. A. (2004). Putative metabolic effects
of the liver X receptor (LXR). Diabetes. 53 Suppl 1: S36-S42.

(49) JUVET, L. K.; ANDRESEN, S. M.; SCHUSTER, G. U.; DALEN, K. T.; TOBIN, K. A.;
HOLLUNG, K.; HAUGEN, F.; JACINTO, S.; ULVEN, S. M.; BAMBERG, K.;
GUSTAFSSON, J. A. AND NEBB, H. I. (2003) On the role of liver X receptors in
lipid accumulation in adipocytes. Mol. Endocrinol. 17: 172-182.

(50) VILLARROYA, F.; IGLESIAS, R. AND GIRALT, M. (2004) Retinoids and retinoid
receptors in the control of energy balance: novel pharmacological strategies in
obesity and diabetes. Curr. Med. Chem. 11: 795-805.

33